April 7, 2016
Having become a benchmark for business angels and other investors as well as for young entrepreneurs seeking funding, the "100 startups to invest in" selection, compiled for the past three years by Challenges magazine, highlights the most innovative companies with the most promising growth prospects.
Ad Scientiam was selected in the "health" category of this 2016 ranking.
Ad Scientiam was selected by a jury of French and German experts for the French Healthcare Booster Germany program, aimed at developing our activities in Germany.
March 9, 2023
Ad Scientiam was selected by the Ile-de-France Regional Council under the PM'up program, as part of the #Leader strategy for innovation.
April 1, 2021
MSCopilot® development was selected for innovation support under the Innov'up Leader PIA program, funded by the State and Île-de-France Region.
August 13, 2020
Talk to our experts and discover how our solutions integrate into your practice or studies.
This site uses analytics cookies
We use Countly to measure audience and improve your experience. This data remains anonymous and is not shared with third parties.